<DOC>
	<DOCNO>NCT02085278</DOCNO>
	<brief_summary>This clinical trial/study patient diagnose brain arteriovenous malformation ( AVM ) . An AVM abnormal connection artery vein brain . Patients consider trial 21 year young AVM suitable embolization treatment ( procedure use block abnormal connection artery vein brain ) Onyx Liquid Embolic System ( Onyx LES ) TruFill n-Butyl Cyanoacrylate ( n-BCA ) Liquid Embolic System ( liquid substance use embolization procedure block abnormal connection ) .</brief_summary>
	<brief_title>Safety Apollo Micro Catheter Pediatric Patients</brief_title>
	<detailed_description>-Why study do ? The purpose study evaluate safety Apollo Embolization Delivery Micro Catheter device ( device look like long thin hallow tube ) use Pediatric patient vascular malformation . The Apollo Onyx Delivery Micro Catheter device manufacture Micro Therapeutics , Inc. d/b/a ev3 Neurovascular . Apollo Onyx™ Delivery Micro Catheter device approve use U.S , although widely use approve use Europe ( CE0297 ) . This clinical study sponsor Dr. Alejandro Berenstein St.Luke's-Roosevelt Hospital , New York also principal Investigator study . Total duration study 30 month approximately 18 month enrollment period . Patients follow period 12 month upon enrollment .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Arteriovenous Malformations</mesh_term>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Vascular Malformations</mesh_term>
	<mesh_term>Central Nervous System Vascular Malformations</mesh_term>
	<mesh_term>Vein Galen Malformations</mesh_term>
	<criteria>The subject subject 's legally authorize representative sign date informed Consent Form . Subject 's age ≤ 21 year . The subject confirm diagnosis brain arteriovenous malformation cerebral cortex , cerebellum dura mater indicate endovascular embolization Onyx™ LES TruFill nButyl Cyanoacrylate ( nBCA ) Liquid Embolic Systems use Apollo Embolization Delivery Micro Catheter may may indicate surgical resection . The subject clinically neurologically stable minimum 48 hour prior embolization . The subject life expectancy least 1 year exception new born baby Vein Galen malformation cardiopulmonary failure treatment option remain . The subject agree capable complete study require procedure Female pregnant lactating . Current participation another investigational drug device study . Subject brain tumor malignancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>arteriovenous malformation</keyword>
	<keyword>Brain</keyword>
	<keyword>AVM</keyword>
	<keyword>Onyx</keyword>
	<keyword>Micro catheter</keyword>
	<keyword>catheter entrapment ,</keyword>
	<keyword>Embolization</keyword>
	<keyword>Vein Of Galen</keyword>
</DOC>